Bosh sahifaSRT3 • FRA
add
Sartorius AG Preference Shares
Yopilish kursi
192,90 €
Kunlik diapazon
191,30 € - 195,80 €
Yillik diapazon
169,45 € - 291,60 €
Bozor kapitalizatsiyasi
13,36 mlrd EUR
Oʻrtacha hajm
254,00
Narx/foyda
129,06
Dividend daromadliligi
0,37%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 884,30 mln | 2,74% |
Joriy xarajat | 284,30 mln | 0,82% |
Sof foyda | 32,50 mln | 35,42% |
Sof foyda marjasi | 3,68 | 31,90% |
Har bir ulushga tushum | 1,22 | 7,02% |
EBITDA | 234,40 mln | 13,51% |
Amaldagi soliq stavkasi | 26,94% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 819,00 mln | 30,96% |
Jami aktivlari | 10,03 mlrd | 0,85% |
Jami passivlari | 6,23 mlrd | 1,64% |
Umumiy kapital | 3,79 mlrd | — |
Tarqatilgan aksiyalar | — | — |
Narxi/balansdagi bahosi | — | — |
Aktivlardan daromad | 3,27% | — |
Kapitaldan daromad | 3,90% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 32,50 mln | 35,42% |
Operatsiyalardan naqd pul | 150,20 mln | -50,17% |
Sarmoyadan naqd pul | -89,50 mln | 13,61% |
Moliyadan naqd pul | -77,90 mln | 89,01% |
Naqd pulning sof oʻzgarishi | -20,60 mln | 95,97% |
Boʻsh pul | -23,64 mln | -124,83% |
Haqida
Sartorius AG is an international pharmaceutical and laboratory equipment supplier. In September 2021, Sartorius was admitted to the DAX, Germany's largest stock market index. Sartorius supports its customers in the development and production of biotech drugs and vaccines. The company has two major divisions: Bioprocess Solutions and Lab Products & Services. Wikipedia
Tashkil etilgan
1870
Sayt
Xodimlar soni
13 685
